Selection and identification of malaria vaccine target molecule using bioinformatics and DNA vaccination

Vaccine

Volumn 28, Issue 42, 2010, Pages 6868-6875

  Shuaibu, M N ^a   Kikuchi, M ^a   Cherif, M S ^a   Helegbe, G K ^a   Yanagi, T ^a   Hirayama, K ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Bioinformatics; DNA vaccine; GPI anchor motif; P. yoelii genome; Protection

Indexed keywords

AMINO ACID; DNA VACCINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; IMMUNOLOGICAL ADJUVANT; MALARIA VACCINE; MESSENGER RNA; PLASMID DNA; RECOMBINANT PROTEIN; TRANSAMIDASE RELATED PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BIOINFORMATICS; C57BL 6 MOUSE; CONTROLLED STUDY; DNA IMMUNIZATION; DRUG DELIVERY SYSTEM; DRUG IDENTIFICATION; EMULSION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FEMALE; GENE SEQUENCE; GENE VECTOR; GENOME ANALYSIS; HYDROPHOBICITY; IMMUNOFLUORESCENCE TEST; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM YOELII; PLASMODIUM YOELII INFECTION; PRIORITY JOURNAL; PROTECTION; PROTEIN DOMAIN; RNA EXTRACTION; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SURVIVAL;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CLONING, MOLECULAR; COMPUTATIONAL BIOLOGY; FEMALE; GENES, PROTOZOAN; GLYCOSYLPHOSPHATIDYLINOSITOLS; IMMUNIZATION, SECONDARY; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED C57BL; PLASMIDS; PLASMODIUM YOELII; RECOMBINANT PROTEINS; VACCINES, DNA;

EID: 77956883146     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.08.019     Document Type: Article

References (29)

1. World Health Organization World Malaria Report 2005 2005, WHO, Geneva.
2. Reed Z.H., Friede M., Kieny M.P. Malaria vaccine development: progress and challenges. Curr Mol Med 2006, 6(2):231-245.
3. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., et al. Direct gene transfer into mouse muscle in vivo. Science 1990, 247(4949 Pt 1):1465-1468.
4. Hoffman S.L., Sedegah M., Hedstrom R.C. Protection against malaria by immunization with a Plasmodium yoelii circumsporozoite protein nucleic acid vaccine. Vaccine 1994, 12:1529-1533.
5. Sedegah M., Hedstrom R., Hobart P., Hoffman S.L. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. Proc Natl Acad Sci USA 1994, 91:9866-9870.
6. Rainczuk A., Scorza T., Spithill T.W., Smooker P.M. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria. Infect Immun 2004, 72(10):5565-5573.
7. Smooker P.M., Rainczuk A., Kennedy N., Spithill T.W. DNA vaccines and their application against parasites-promise, limitations and potential solutions. Biotechnol Annu Rev 2004, 10:189-236.
8. Brice G.T., Dobaño C., Sedegah M., Stefaniak M., Graber N.L., Campo J.J., et al. Extended immunization intervals enhance the immunogenicity and protective efficacy of plasmid DNA vaccines. Microbes Infect 2007, 9(12-13):1439-1446.
9. Jiang G., Charoenvit Y., Moreno A., Baraceros M.F., Banania G., Richie N., et al. Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization. Malar J 2007, 6(135):1-17.
10. Doolan D.L., Southwood S., Freilich D.A., Sidney J., Graber N.L., Shatney L., et al. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc Natl Acad Sci USA 2003, 100(17):9952-9957.
11. Gardner M.J., Hall N., Fung E., White O., Berriman M., Hyman R.W., et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002, 419:498-511.
12. Carlton J.M., Angiuoli S.V., Suh B.B., Kooij T.W., Pertea M., Silva J.C., et al. Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature 2002, 419:512-519.
13. Hoffman S.L. Malaria: a protective paradox. Nature 2006, 444(7121):824-827.
14. Florens L., Liu X., Wang Y., Yang S., Schwartz O., Peglar M., et al. Proteomics approach reveals novel proteins on the surface of malaria-infected erythrocytes. Mol Biochem Parasitol 2004, 135:1-11.
15. Le Roch K.G., Johnson J.R., Florens L., Zhou Y., Santrosyan A., Grainger M., et al. Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle. Genome Res 2004, 14:2308-2318.
16. Gilson P.R., Nebl T., Vukcevic D., Moritz R.L., Sargeant T., Speed T.P., et al. Identification and stoichiometry of glycosylphosphatidylinositol-anchored membrane proteins of the human malaria parasite Plasmodium falciparum. Mol Cell Proteomics 2006, 5(7):1286-1299.
17. Bahl A., Brunk B., Crabtree J., Fraunholz M.J., Gajria B., Grant G.R., et al. PlasmoDB: the Plasmodium genome resource. A database integrating experimental and computational data. Nucleic Acids Res 2003, 31(1):212-215.
18. Steve Rozen S., Helen J., Skaletsky H.J. Primer3 on the WWW for general users and for biologist programmers. Bioinformatics methods and protocols: methods in molecular biology 2000, 365-386. Humana Press, Totowa, NJ, Source code available at http://fokker.wi.mit.edu/primer3/. S. Krawetz, S. Misener (Eds.).
19. Aguiar J.C., LaBaer J., Blair P.L., Shamailova V.Y., Koundinya M., Russell J.A., et al. High-throughput generation of P. falciparum functional molecules by recombinational cloning. Genome Res 2004, 14(10B):2076-2082.
20. Haddad D., Bilcikova E., Witney A.A., Carlton J.M., White C.E., Blair P.L., et al. Novel antigen identification method for discovery of protective malaria antigens by rapid testing of DNA vaccines encoding exons from the parasite genome. Infect Immun 2004, 72(3):1594-1602.
21. Regis D.P., Dobaño C., Quiñones-Olson P., Liang X., Graber N.L., Stefaniak M.E., et al. Transcriptionally active PCR for antigen identification and vaccine development: in vitro genome-wide screening and in vivo immunogenicity. Mol Biochem Parasitol 2007, 158:32-45.
22. Zhu J., Krishnegowda G., Gowda D.C. Induction of proinflammatory responses in macrophages by the glycosylphosphatidylinositols of Plasmodium falciparum: the requirement of extracellular signal-regulated kinase, p38, c-Jun N-terminal kinase and NF-kappaB pathways for the expression of proinflammatory cytokines and nitric oxide. J Biol Chem 2005, 280(9):8617-8627.
23. Basagoudanavar S.H., Feng X., Krishnegowda G., Muthusamy A., Gowda D.C. Plasmodium falciparum GPI mannosyltransferase-III has novel signature sequence and is functional. Biochem Biophys Res Commun 2007, 364(4):748-754.
24. Nussenzweig V., Nussenzweig R.S. Circumsporozoite proteins of malaria parasites. Cell 1985, 42:401-403.
25. Holder A.A., Lockyer M.J., Odink K.G., Sandhu J.S., Riveros M.V., Davey L.S., et al. Primary structure of the precursor to the three major surface antigens of Plasmodium falciparum merozoites. Nature 1985, 317:270-273.
26. Moorthy V.S., Good M.F., Hill A.V. Malaria vaccine developments. Lancet 2004, 363:150-156.
27. Soe S., Theisen M., Roussilhon C., Aye K.S., Druilhe P. Association between protection against clinical malaria and antibodies to merozoite surface antigens in an area of hyperendemicity in Myanmar: complementarity between responses to merozoite surface protein 3 and the 220-kilodalton glutamate-rich protein. Infect Immun 2004, 72:247-252.
28. Carter K.C., Henriquez F.L., Campbell S.A., Roberts C.W., Nok A., Mullen A.B., et al. DNA vaccination against the parasite enzyme gamma-glutamylcysteine synthetase confers protection against Leishmania donovani infection. Vaccine 2007, 25:4502-4509.
29. Gamboa-Leon R., Paraguai de Souza E., Borja-Cabrera G.P., Santos F.N., Myashiro L.M., Pinheiro R.O., et al. Immunotherapy against visceral leishmaniasis with the nucleoside hydrolase DNA vaccine of Leishmania donovani. Vaccine 2006, 24:4863-4874.